Skip to main content

Table 4 The IC50 of 5-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-sulfonamide (LLL12) for primary cells of feline injection site sarcoma (FISS) and feline normal soft tissue (FNST) following 24 or 72 hours of incubation

From: Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma

 

IC50 of LLL12 (μM)

Cell

24 hours

72 hours

FISS-10

0.2999

0.2231

FISS-14

0.5061

0.4510

FNST

1.697

1.665